We are live on ! Find out more
HC

Hampstead Capital Portfolio holdings

AUM $55.8M
1-Year Est. Return 2.76%
This Fund
S&P 500
This Quarter Est. Return
+2.14%
1 Year Est. Return
+2.76%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.3M
AUM Growth
–
Cap. Flow
+$91.3M
Cap. Flow %
96.83%
Top 10 Hldgs %
50.52%
Holding
29
New
29
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7.17M
2
T icon
AT&T
T
+$6.54M
3
VTRS icon
Viatris
VTRS
+$4.83M
4
CELG
Celgene Corp
CELG
+$4.45M
5
AAPL icon
Apple
AAPL
+$4.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 27.07%
2 Communication Services 17.14%
3 Technology 12.68%
4 Energy 12.25%
5 Financials 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WLK icon
26
Westlake Corp
WLK
$9.03B
$1.4M 1.49%
+25,000
New +$1.37M
CTRA
27
DELISTED
Coterra Energy
CTRA
$771K 0.82%
+33,000
New +$742K
AVP
28
DELISTED
Avon Products, Inc.
AVP
$504K 0.53%
+100,000
New +$581K
XPRO icon
29
Expro Ltd
XPRO
$1.79B
$492K 0.52%
+6,667
New +$489K
1
2

Similar funds

CCP
Centaur Capital Partners Southlake, Texas $54.1M AUM 12.4% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
CLA
Cranberry Lake Advisors Houston, Texas $50.6M AUM 5.12% 1-Year Est. Return
EIC
ENA Investment Capital London, United Kingdom $61.8M AUM
SF
Schooner Foundation Boston, Massachusetts $49.6M AUM 9.4% 1-Year Est. Return
DIV
DCM International V Menlo Park, California $47.8M AUM 19.52% 1-Year Est. Return
MGPI
Maveron General Partner III Seattle, Washington $46.7M AUM 35.29% 1-Year Est. Return
BOIA
Bush ODonnell Investment Advisors St Louis, Missouri $65.2M AUM 13.39% 1-Year Est. Return

Hampstead Capital's Q4 2016 Portfolio in Review

Q4 2016 is the first quarter with a 13F filing on record for Hampstead Capital, which disclosed 29 positions worth $94.3M. Its ten largest holdings account for 51% of the portfolio.

Its largest position is Pfizer: 234,726 shares worth $7.23M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, followed by Communication Services and Technology.

  • Hampstead Capital's largest Q4 2016 buy was Pfizer: 234,726 shares worth $7.23M.
  • Hampstead Capital's ten largest holdings make up 51% of its $94.3M portfolio in Q4 2016.
  • Hampstead Capital disclosed 29 positions in Q4 2016, its first 13F filing on record.

Based on Hampstead Capital's 13F filing for Q4 2016, filed 14 Feb 2017.